Sam Altman has not signed the Pacing the Frontier statement since its July 2026 launch, even as over 1,300 frontier lab employees—including OpenAI’s chief scientist—endorsed the call for U.S.-backed international tools to manage automated AI research risks. Trader consensus at 95% “No” by September 30 reflects Altman’s consistent pattern of voicing support for deliberate pacing without joining employee-led pledges, citing concerns over regulatory capture or perceived collusion among labs. Recent September statements show him aligning publicly with Anthropic’s Dario Amodei on embedded evaluators and safety costs, yet he has stopped short of adding his name to this specific document. With just weeks remaining, a late signature remains possible if internal or external pressure shifts, though the deadline’s proximity and his prior restraint reinforce the market’s strong “No” positioning.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedA qualifying listing must identify Sam Altman by name together with his role at OpenAI, or otherwise make clear that the signatory is the CEO of OpenAI. Once Sam Altman is listed or confirms signing, this market will resolve to "Yes" regardless of whether his name is later removed or the statement is later amended.
The primary resolution source for this market will be the signatory list at pacingthefrontier.com; however, official statements from Sam Altman or OpenAI and a consensus of credible reporting may also be used.
Market Opened: Sep 14, 2026, 6:46 PM ET
Resolver
0x65070BE91...A qualifying listing must identify Sam Altman by name together with his role at OpenAI, or otherwise make clear that the signatory is the CEO of OpenAI. Once Sam Altman is listed or confirms signing, this market will resolve to "Yes" regardless of whether his name is later removed or the statement is later amended.
The primary resolution source for this market will be the signatory list at pacingthefrontier.com; however, official statements from Sam Altman or OpenAI and a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Sam Altman has not signed the Pacing the Frontier statement since its July 2026 launch, even as over 1,300 frontier lab employees—including OpenAI’s chief scientist—endorsed the call for U.S.-backed international tools to manage automated AI research risks. Trader consensus at 95% “No” by September 30 reflects Altman’s consistent pattern of voicing support for deliberate pacing without joining employee-led pledges, citing concerns over regulatory capture or perceived collusion among labs. Recent September statements show him aligning publicly with Anthropic’s Dario Amodei on embedded evaluators and safety costs, yet he has stopped short of adding his name to this specific document. With just weeks remaining, a late signature remains possible if internal or external pressure shifts, though the deadline’s proximity and his prior restraint reinforce the market’s strong “No” positioning.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions